ACE2: A Dilemma in Regulating SARS-CoV-2 Infection and its Metabolic Complications

ACE2: A Dilemma in Regulating SARS-CoV-2 Infection and its Metabolic Complications

Bibliographic Details
Main Author:	Yan-Chuan Shi
Format:	Article
Language:	English
Published:	Compuscript Ltd 2023-05-01
Series:	BIO Integration
Online Access:	https://www.ingentaconnect.com/contentone/cscript/bioi/2023/00000004/00000001/art00002

Similar Items

Development of ACE2 autoantibodies after SARS-CoV-2 infection.
by: John M Arthur, et al.
Published: (2021-01-01)

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
by: Marie-Kristin Kroll, et al.
Published: (2023-03-01)

Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.
by: Nidhi Shukla, et al.
Published: (2021-07-01)

ACE2: the molecular doorway to SARS-CoV-2
by: Miriam Marlene Medina-Enríquez, et al.
Published: (2020-12-01)

Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
by: Hui Han, et al.
Published: (2024-02-01)

Does SARS-CoV-2 bind to human ACE2 stronger than SARS-CoV?
by: Nguyen, HL, et al.
Published: (2020)

The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
by: Shuwei Li, et al.
Published: (2022-07-01)

Correction: Development of ACE2 autoantibodies after SARS-CoV-2 infection.
by: John M Arthur, et al.
Published: (2024-01-01)

Disrupting ACE2 Dimerization Mitigates the Infection by SARS-CoV-2 Pseudovirus
by: Jiaqi Zhu, et al.
Published: (2022-07-01)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
by: Takanari Hattori, et al.
Published: (2022-08-01)

ACE2-Independent Alternative Receptors for SARS-CoV-2
by: Suhyeon Lim, et al.
Published: (2022-11-01)

The glycosylation in SARS-CoV-2 and its receptor ACE2
by: Yanqiu Gong, et al.
Published: (2021-11-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2
by: Qian-wen Yang, et al.
Published: (2024-12-01)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
by: Vanessa Monteil, et al.
Published: (2020-12-01)

ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
by: Krystal L Ching, et al.
Published: (2022-09-01)

Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
by: Airu Zhu, et al.
Published: (2021-03-01)

Independent Tendency of ACE2 and GRP78 Expression in SARS-CoV2 Infection
by: Arya Adiningrat, et al.
Published: (2022-07-01)

Ginseng Protects ACE2-Transgenic Mice from SARS-CoV-2 Infection
by: Sang Heui Seo
Published: (2022-06-01)

Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection
by: Mario Dioguardi, et al.
Published: (2021-07-01)

Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels
by: Qiru Zeng, et al.
Published: (2024-03-01)

SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
by: Rajkumar Singh Kalra, et al.
Published: (2020-07-01)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

Investigation of Interactions Between Sedative, Analgesic and Anaesthetic Drugs with SARS-CoV-2, ACE-2 and SARS-CoV-2- ACE-2 Complex by Molecular Docking Method
by: Evren Büyükfırat, et al.
Published: (2021-12-01)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
by: Claudio Fenizia, et al.
Published: (2021-06-01)

Role of SARS-CoV-2 and ACE2 variations in COVID-19
by: Priya Antony, et al.
Published: (2021-06-01)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
by: Francesca Salamanna, et al.
Published: (2020-12-01)

The molecular basis for SARS-CoV-2 binding to dog ACE2
by: Zengyuan Zhang, et al.
Published: (2021-07-01)

Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids
by: Sarah L. O’Beirne, et al.
Published: (2021-07-01)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
by: Christopher J. Day, et al.
Published: (2021-04-01)

Potential complications and sequelae of SARS-CoV-2 infection
by: Jyoti Nath Modi, et al.
Published: (2021-01-01)

Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
by: Chaja Katzman, et al.
Published: (2021-12-01)

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
by: Brevini, T, et al.
Published: (2022)

ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
by: Bayraktar C, et al.
Published: (2024-07-01)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
by: Raveen Rathnasinghe, et al.
Published: (2020-01-01)

Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection
by: Hao Sun, et al.
Published: (2021-01-01)

ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
by: Géraldine Descamps, et al.
Published: (2020-08-01)

ACE2‐enriched extracellular vesicles enhance infectivity of live SARS‐CoV‐2 virus
by: Sze Keong Tey, et al.
Published: (2022-05-01)